{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T19:10:59Z","timestamp":1770491459920,"version":"3.49.0"},"reference-count":73,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T00:00:00Z","timestamp":1672704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"FEDER"},{"name":"Portuguese funds"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>The antiretroviral drug, the total level of viral production, and the effectiveness of immune responses are the main topics of this review because they are all dynamically interrelated. Immunological and viral processes interact in extremely complex and non-linear ways. For reliable analysis and quantitative forecasts that may be used to follow the immune system and create a disease profile for each patient, mathematical models are helpful in characterizing these non-linear interactions. To increase our ability to treat patients and identify individual differences in disease development, immune response profiling might be useful. Identifying which patients are moving from mild to severe disease would be more beneficial using immune system parameters. Prioritize treatments based on their inability to control the immune response and prevent T cell exhaustion. To increase treatment efficacy and spur additional research in this field, this review intends to provide examples of the effects of modelling immune response in viral infections, as well as the impact of pharmaceuticals on immune response.<\/jats:p>","DOI":"10.3390\/pharmaceutics15010167","type":"journal-article","created":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T01:42:44Z","timestamp":1672796564000},"page":"167","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Modulating Immune Response in Viral Infection for Quantitative Forecasts of Drug Efficacy"],"prefix":"10.3390","volume":"15","author":[{"given":"B\u00e1rbara","family":"Costa","sequence":"first","affiliation":[{"name":"OncoPharma Research Group, Center for Health Technology and Services Research (CINTESIS), Rua Doutor Pl\u00e1cido da Costa, 4200-450 Porto, Portugal"},{"name":"CINTESIS@RISE, Faculty of Medicine, University of Porto, Alameda Professor Hern\u00e2ni Monteiro, 4200-319 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1283-1042","authenticated-orcid":false,"given":"Nuno","family":"Vale","sequence":"additional","affiliation":[{"name":"OncoPharma Research Group, Center for Health Technology and Services Research (CINTESIS), Rua Doutor Pl\u00e1cido da Costa, 4200-450 Porto, Portugal"},{"name":"CINTESIS@RISE, Faculty of Medicine, University of Porto, Alameda Professor Hern\u00e2ni Monteiro, 4200-319 Porto, Portugal"},{"name":"Department of Community Medicine, Information and Health Decision Sciences (MEDCIDS), Faculty of Medicine, University of Porto, Rua Doutor Pl\u00e1cido da Costa, 4200-450 Porto, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"672026","DOI":"10.3389\/fmicb.2021.672026","article-title":"Acute Infection of Viral Pathogens and Their Innate Immune Escape","volume":"12","author":"Rai","year":"2021","journal-title":"Front. Microbiol."},{"key":"ref_2","unstructured":"Baron, S. (1996). Persistent Viral Infections. Medical Microbiology, University of Texas Medical Branch at Galveston. [4th ed.]. Chapter 46."},{"key":"ref_3","first-page":"115","article-title":"Cancer issue: Viruses and Human Cancer","volume":"79","author":"Lambert","year":"2006","journal-title":"Yale J. Biol. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.coisb.2018.10.005","article-title":"Validated models of immune response to virus infection","volume":"12","author":"Smith","year":"2018","journal-title":"Curr. Opin. Syst. Biol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.3389\/fmicb.2018.01546","article-title":"Mathematical analysis of viral replication dynamics and antiviral treatment strategies: From basic models to age-based multi-scale modeling","volume":"9","author":"Zitzmann","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s40262-020-00924-9","article-title":"Pharmacokinetics\/Pharmacodynamics of Antiviral Agents Used to Treat SARS-CoV-2 and Their Potential Interaction with Drugs and Other Supportive Measures: A Comprehensive Review by the PK\/PD of Anti-Infectives Study Group of the European Society of Antimicrobial Agents","volume":"59","author":"Zeitlinger","year":"2020","journal-title":"Clin. Pharmacokinet."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"20587384211002621","DOI":"10.1177\/20587384211002621","article-title":"A review: Mechanism of action of antiviral drugs","volume":"35","author":"Kausar","year":"2021","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41591-021-01282-0","article-title":"Developing therapeutic approaches for twenty-first-century emerging infectious viral diseases","volume":"27","author":"Meganck","year":"2021","journal-title":"Nat. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1016\/j.jmb.2018.06.024","article-title":"Virus\u2013Receptor Interactions: The Key to Cellular Invasion","volume":"430","author":"Maginnis","year":"2018","journal-title":"J. Mol. Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"116356","DOI":"10.1016\/j.bmc.2021.116356","article-title":"Antiviral strategies targeting host factors and mechanisms obliging +ssRNA viral pathogens","volume":"46","author":"Mahajan","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coviro.2017.03.009","article-title":"Direct-acting antivirals and host-targeting strategies to combat enterovirus infections","volume":"24","author":"Bauer","year":"2017","journal-title":"Curr. Opin. Virol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1126\/science.abf6446","article-title":"Lessons in antiviral immunity","volume":"371","author":"Hope","year":"2021","journal-title":"Science"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s00285-018-1241-y","article-title":"Multiscale model within-host and between-host for viral infectious diseases","volume":"77","author":"Almocera","year":"2018","journal-title":"J. Math. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.coviro.2021.07.007","article-title":"Advancing therapies for viral infections using mechanistic computational models of the dynamic interplay between the virus and host immune response","volume":"50","author":"Zarnitsyna","year":"2021","journal-title":"Curr. Opin. Virol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1142\/S0218202520500323","article-title":"A multiscale model of virus pandemic: Heterogeneous interactive entities in a globally connected world","volume":"30","author":"Bellomo","year":"2020","journal-title":"Math. Model. Methods Appl. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/imr.12671","article-title":"Dynamic balance of pro- and anti-inflammatory signals controls disease and limits pathology","volume":"285","author":"Cicchese","year":"2018","journal-title":"Immunol. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"20210307","DOI":"10.1098\/rsta.2021.0307","article-title":"Compositional modelling of immune response and virus transmission dynamics","volume":"380","author":"Waites","year":"2022","journal-title":"Philos. Trans. R. Soc. A"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.ajic.2019.11.005","article-title":"Simulation models for transmission of health care\u2013associated infection: A systematic review","volume":"48","author":"Nguyen","year":"2020","journal-title":"Am J Infect Control."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41577-019-0235-3","article-title":"Thomas PGSimulation modelling for immunologists","volume":"20","author":"Handel","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Perelson, A.S. (2013). Ribeiro RMModeling the within-host dynamics of HIV infection. BMC Biol., 11.","DOI":"10.1186\/1741-7007-11-96"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/cpt.2160","article-title":"Mechanistic modelling of SARS-CoV-2 and other infectious diseases and the effects of therapeutics","volume":"109","author":"Perelson","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Venugopal, V., Padmanabhan, P., Raja, R., and Dixit, N.M. (2018). Modelling how responsiveness to interferon improves interferon-free treatment of hepatitis C virus infection. PLoS Comput. Biol., 14.","DOI":"10.1371\/journal.pcbi.1006335"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1038\/s41598-020-58600-8","article-title":"Integrative network modeling reveals mechanisms underlying T cell exhaustion","volume":"10","author":"Bolouri","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"104862","DOI":"10.1016\/j.antiviral.2020.104862","article-title":"Modeling based response guided therapy in subjects with recent hepatitis C infection","volume":"180","author":"Gorstein","year":"2020","journal-title":"Antivir. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.antiviral.2017.06.019","article-title":"Modeling HCV cure after an ultra-short duration of therapy with direct acting agents","volume":"144","author":"Goyal","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/imcb.12161","article-title":"Modeling how reversal of immune exhaustion elicits cure of chronic hepatitis C after the end of treatment with direct-acting antiviral agents","volume":"96","author":"Baral","year":"2018","journal-title":"Immunol. Cell Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3934\/mbe.2004.1.267","article-title":"An age-structured model of hiv infection that allows for variations in the production rate of viral particles and the death rate of productively infected cells","volume":"1","author":"Nelson","year":"2004","journal-title":"Math. Biosci. Eng."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Rampersad, S., and Tennant, P. (2018). Replication and Expression Strategies of Viruses. Viruses: Molecular Biology, Host Interactions and Applications to Biotechnology, Academic Press.","DOI":"10.1016\/B978-0-12-811257-1.00003-6"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"731340","DOI":"10.3389\/fbinf.2021.731340","article-title":"A Mechanistic Site-Of-Action Model: A Tool for Informing Right Target, Right Compound, and Right Dose for Therapeutic Antagonistic Antibody Programs","volume":"1","author":"Kapitanov","year":"2021","journal-title":"Front. Bioinform."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/B978-0-12-809633-8.21290-9","article-title":"Antiviral Innate Immunity: Introduction","volume":"1","author":"Weber","year":"2021","journal-title":"Encycl. Virol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"9624","DOI":"10.1016\/j.vaccine.2011.10.047","article-title":"Vaccination by Delayed Treatment of Infection","volume":"29","author":"Stromberg","year":"2011","journal-title":"Vaccine"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1146\/annurev-immunol-030409-101317","article-title":"Systems biology in immunology: A computational modeling perspective","volume":"29","author":"Germain","year":"2011","journal-title":"Annu Rev Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/s42256-020-00232-8","article-title":"Integration of mechanistic immunological knowledge into a machine learning pipeline improves predictions","volume":"2","author":"Culos","year":"2020","journal-title":"Nat. Mach. Intell."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"a008151","DOI":"10.1101\/cshperspect.a008151","article-title":"Signaling in cell differentiation and morphogenesis","volume":"4","author":"Basson","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1126\/science.272.5258.74","article-title":"Population dynamics of immune responses to persistent viruses","volume":"272","author":"Nowak","year":"1996","journal-title":"Science"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/j.1541-0420.2007.00812.x","article-title":"Maximum likelihood estimation in dynamical models of HIV","volume":"63","author":"Guedj","year":"2007","journal-title":"Biometrics"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nature04017","article-title":"Strategies for containing an emerging influenza pandemic in Southeast Asia","volume":"437","author":"Ferguson","year":"2005","journal-title":"Nature"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.289.2.179","article-title":"Mortality associated with influenza and respiratory syncytial virus in the United States","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"108973","DOI":"10.1016\/j.asoc.2022.108973","article-title":"Generalized Susceptible-Exposed-Infectious-Recovered model and its contributing factors for analysing the death and recovery rates of the COVID-19 pandemic","volume":"123","author":"Wilta","year":"2022","journal-title":"Appl. Soft Comput."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"110057","DOI":"10.1016\/j.chaos.2020.110057","article-title":"A SIR model assumption for the spread of COVID-19 in different communities","volume":"139","author":"Cooper","year":"2020","journal-title":"Chaos Solitons Fractals"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.cell.2021.02.029","article-title":"COVID-19 and the human innate immune system","volume":"184","author":"Schultze","year":"2021","journal-title":"Cell"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s15010-021-01610-z","article-title":"COVID-19 is not \u201cjust another flu\u201d: A real-life comparison of severe COVID-19 and influenza in hospitalized patients in Vienna, Austria","volume":"49","author":"Pawelka","year":"2021","journal-title":"Infection"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.3389\/fimmu.2019.02350","article-title":"IL-2 Restores T-Cell Dysfunction Induced by Persistent Mycobacterium tuberculosis Antigen Stimulation","volume":"10","author":"Liu","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.3389\/fimmu.2018.02569","article-title":"T-Cell Exhaustion in Chronic Infections: Reversing the State of Exhaustion and Reinvigorating Optimal Protective Immune Responses","volume":"9","author":"Saeidi","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/s42255-022-00652-3","article-title":"Innate metabolic responses against viral infections","volume":"4","author":"Palmer","year":"2022","journal-title":"Nat. Metab."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.3389\/fimmu.2020.594963","article-title":"Virus Infections and Host Metabolism\u2014Can We Manage the Interactions?","volume":"11","author":"Sumbria","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.7150\/jca.27279","article-title":"Oncogenic virus-induced aerobic glycolysis and tumorigenesis","volume":"9","author":"Yu","year":"2018","journal-title":"J. Cancer"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1046755","DOI":"10.3389\/fimmu.2022.1046755","article-title":"Targeting T-cell metabolism to boost immune checkpoint inhibitor therapy","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Stirling, E.R., Bronson, S.M., Mackert, J.D., Cook, K.L., Triozzi, P.L., and Soto-Pantoja, D.R. (2022). Metabolic Implications of Immune Checkpoint Proteins in Cancer. Cells, 11.","DOI":"10.3390\/cells11010179"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e004564","DOI":"10.1136\/jitc-2022-004564","article-title":"Patients with HIV-associated cancers have evidence of increased T cell dysfunction and exhaustion prior to cancer diagnosis","volume":"10","author":"Chaudhary","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Cai, H., Liu, G., Zhong, J., Zheng, K., Xiao, H., Li, C., Song, X., Li, Y., Xu, C., and Wu, H. (2020). Immune Checkpoints in Viral Infections. Viruses, 12.","DOI":"10.3390\/v12091051"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.3389\/fimmu.2020.585819","article-title":"The Therapeutic Potential of Regulatory T Cells: Challenges and Opportunities","volume":"11","author":"Bayati","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Baron, M., Souli\u00e9, C., Lavol\u00e9, A., Assoumou, L., Abbar, B., Fouquet, B., Rousseau, A., Veyri, M., Samri, A., and Makinson, A. (2022). Impact of Anti PD-1 Immunotherapy on HIV Reservoir and Anti-Viral Immune Responses in People Living with HIV and Cancer. Cells, 11.","DOI":"10.3390\/cells11061015"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/QAD.0000000000002406","article-title":"T cells with high PD-1 expression are associated with lower HIV-specific immune responses despite long-term antiretroviral therapy","volume":"34","author":"Macatangay","year":"2020","journal-title":"AIDS"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nature07662","article-title":"Enhancing SIV-Specific Immunity In Vivo by PD-1 Blockade","volume":"458","author":"Velu","year":"2009","journal-title":"Nature"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1172\/JCI133222","article-title":"Thimme RCD4+ T cell responses in human viral infection: Lessons from hepatitis C","volume":"130","author":"Binder","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1053\/j.gastro.2008.02.033","article-title":"Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization","volume":"134","author":"Nakamoto","year":"2008","journal-title":"Gastroenterology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.immuni.2016.07.008","article-title":"Bioenergetic insufficiencies due to metabolic alterations regulated by PD-1 are an early driver of CD8+ T cell exhaustion","volume":"45","author":"Bengsch","year":"2016","journal-title":"Immunity"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1210\/er.2002-0012","article-title":"Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): Transcriptional coactivator and metabolic regulator","volume":"24","author":"Puigserver","year":"2003","journal-title":"Endocr. Rev."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Schank, M., Zhao, J., Moorman, J.P., and Yao, Z.Q. (2021). The Impact of HIV- and ART-Induced Mitochondrial Dysfunction in Cellular Senescence and Aging. Cells, 10.","DOI":"10.3390\/cells10010174"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.immuni.2012.10.020","article-title":"Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling","volume":"38","author":"Sena","year":"2013","journal-title":"Immunity"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.celrep.2016.06.078","article-title":"Distinct Metabolic Requirements of Exhausted and Functional Virus-Specific CD8 T Cells in the Same Host","volume":"16","author":"Schurich","year":"2016","journal-title":"Cell Rep."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"104989","DOI":"10.1016\/j.antiviral.2020.104989","article-title":"Metabolic regulation of the HBV-specific T cell function","volume":"185","author":"Barili","year":"2021","journal-title":"Antivir. Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"923","DOI":"10.20892\/j.issn.2095-3941.2020.0338","article-title":"Exhausted T cells and epigenetic status","volume":"17","author":"Zeng","year":"2020","journal-title":"Cancer Biol. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13045-018-0636-y","article-title":"Memory T cells skew toward terminal differentiation in the CD8+ T cell population in patients with acute myeloid leukemia","volume":"11","author":"Xu","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1152\/advan.00066.2013","article-title":"T cell responses: Na\u00efve to memory and everything in between","volume":"37","author":"Pennock","year":"2013","journal-title":"Adv. Physiol. Educ."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1038\/s41598-022-05474-7","article-title":"T cell subtype profiling measures exhaustion and predicts anti-PD-1 response","volume":"12","author":"Schillebeeckx","year":"2022","journal-title":"Sci Rep."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1038\/s41416-022-01743-4","article-title":"Biomarkers of response to PD-1 pathway blockade","volume":"126","author":"Li","year":"2022","journal-title":"Br. J. Cancer"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1186\/s12967-021-03136-2","article-title":"Ibrutinib protects T cells in patients with CLL from proliferation-induced senescence","volume":"19","author":"Davis","year":"2021","journal-title":"J. Transl. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1128\/JVI.02034-13","article-title":"Differential impact of PD-1 and\/or interleukin-10 blockade on HIV-1-specific CD4 T cell and antigen-presenting cell functions","volume":"88","author":"Porichis","year":"2014","journal-title":"J. Virol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1084\/jem.20061462","article-title":"Resolution of a chronic viral infection after interleukin-10 receptor blockade","volume":"203","author":"Ejrnaes","year":"2006","journal-title":"J. Exp. Med."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Braun, M.Y. (2021). The Natural History of T Cell Metabolism. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22136779"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e148546","DOI":"10.1172\/JCI148546","article-title":"Targeting memory T cell metabolism to improve immunity","volume":"132","author":"Corrado","year":"2022","journal-title":"J Clin Investig."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/15\/1\/167\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T17:57:35Z","timestamp":1760119055000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/15\/1\/167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,3]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["pharmaceutics15010167"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics15010167","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,3]]}}}